01.03.2010
Novel Syntaxin 11 Gene (STX11) Mutation in Three Argentinean Patients with Hemophagocytic Lymphohistiocytosis
verfasst von:
Silvia Danielian, Natalia Basile, Carlos Rocco, Emma Prieto, Jorge Rossi, Darío Barsotti, Paul A. Roche, Andrea Bernasconi, Matías Oleastro, Marta Zelazko, Jorge Braier
Erschienen in:
Journal of Clinical Immunology
|
Ausgabe 2/2010
Einloggen, um Zugang zu erhalten
Abstract
Introduction
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease with major diagnostic and therapeutic difficulties, basically comprising two different conditions: primary and secondary forms. Recent advances regarding molecular diagnosis may be useful to distinguish from one another, especially in sporadic cases starting in early infancy.
Materials and Methods
In this report, we evaluated three Argentinean patients with clinical suspicion of HLH, but without family history. We excluded mutations in the perforin gene but identified in the three patients a novel homozygous deletion (c. 581_584delTGCC; p.Leu194ProfsX2) in the gene-encoding syntaxin 11 (STX11), causing a premature termination codon.
Results and Conclusion
Each parent from the three unrelated families resulted heterozygous for this deletion confirming the diagnosis of familial hemophagocytic lymphohistiocytosis type 4. Patients shared the same single-nucleotide polymorphism profile in STX11 gene, and genotyping at ten microsatellites surrounding this gene support the presence of a single-haplotype block carrying the novel mutation.